2011-23: Roadmap to Remission: A Practice-Ready Protocol for an Outpatient Esketamine Program
-
Register
- Non-member - $13
- Regular Member - $8
- Retired Member - $8
- Affiliate Member - $8
- Student Member - $8
Internet Explorer does not cooperate with this site. Please see below for options that work with APNA eLearning.*
2011-23: Roadmap to Remission: A Practice-Ready Protocol for an Outpatient Esketamine Program
Come for an illuminating illustration of a protocol for safely starting an esketamine treatment program in private practice. Stay for an engaging discussion of the evidence base, patient experiences, and lessons learned from 18 months offering this novel therapy.
Presenter: David Madden, RN
Disclosures: The APNA planners and faculty have no relevant financial relationships to disclose. Off-label uses will not be discussed during this presentation.
Session Length: 45 minutes
Target Audience: RN, APRN
Learning Outcome:
Upon completion of this presentation, the participant will be able to:
- Describe a protocol for safely and effectively administering esketamine for patients with TRD in a private practice setting.
Keywords: Esketamine, Psychedelic, Depression
Nursing Continuing Professional Development:
0.75 pharmacology contact hours. * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.
The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Originally Presented
APNA 37th Annual Conference
Lake Buena Vista, FL
Access to this course will end: November 30, 2025
*For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.